Literature DB >> 18024186

Diabetes, sugar-coated but harmful to the brain.

Vanessa L Starr1, Antonio Convit.   

Abstract

Type 2 diabetes mellitus appears to directly impair cognition and brain function, independent of its associated cardiovascular disease. This is supported by the presence of similar findings among adults with insulin resistance (pre-diabetes) and obese children with type 2 diabetes, years before overt cardiovascular disease. Hippocampal based memory performance is impaired early in the disease, although deficits in executive function, attention, and psychomotor speed are also seen in more chronic disease and/or poorer disease control, particularly in the presence of co-morbidities such as hypertension. Although there has been some speculation as to possible links between diabetes and Alzheimer's Disease based on associations found in population studies, no convincing empirical evidence has been put forth and brain autopsy studies, the gold standard of Alzheimer's diagnosis, have not supported such a link. Future studies should focus on understanding the mechanisms for the cognitive impairments associated with type 2 diabetes. We propose that insulin resistance-associated impairments in vascular reactivity and endothelial function are possible candidates as they may impact substrate delivery across the blood-brain-barrier. These are important issues given the obesity epidemic and the associated rising prevalence of insulin resistance and type 2 diabetes.

Entities:  

Mesh:

Year:  2007        PMID: 18024186      PMCID: PMC2170066          DOI: 10.1016/j.coph.2007.10.007

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  46 in total

1.  Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.

Authors:  M Baldereschi; A Di Carlo; V Lepore; L Bracco; S Maggi; F Grigoletto; G Scarlato; L Amaducci
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

2.  Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

Authors:  E Ferrannini; A Natali; P Bell; P Cavallo-Perin; N Lalic; G Mingrone
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Aspirin, anti-inflammatory drugs and risk of dementia.

Authors:  A S Henderson; A F Jorm; H Christensen; P A Jacomb; A E Korten
Journal:  Int J Geriatr Psychiatry       Date:  1997-09       Impact factor: 3.485

4.  Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function.

Authors:  M Vanhanen; K Koivisto; L Karjalainen; E L Helkala; M Laakso; H Soininen; P Riekkinen
Journal:  Neuroreport       Date:  1997-04-14       Impact factor: 1.837

5.  Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

Authors:  J Heitner; D Dickson
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

6.  Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes.

Authors:  Sanne M Manschot; Augustina M A Brands; Jeroen van der Grond; Roy P C Kessels; Ale Algra; L Jaap Kappelle; Geert Jan Biessels
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

Review 7.  Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies.

Authors:  M W Strachan; I J Deary; F M Ewing; B M Frier
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

8.  The effects of type 1 diabetes on cognitive performance: a meta-analysis.

Authors:  Augustina M A Brands; Geert Jan Biessels; Edward H F de Haan; L Jaap Kappelle; Roy P C Kessels
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

9.  Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications.

Authors:  B M Lobnig; O Krömeke; C Optenhostert-Porst; O T Wolf
Journal:  Diabet Med       Date:  2006-01       Impact factor: 4.359

10.  Impact of plasma lipids and time on memory performance in healthy elderly without dementia.

Authors:  C Reitz; J Luchsinger; M-X Tang; J Manly; R Mayeux
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

View more
  11 in total

1.  Disruption of circadian clocks has ramifications for metabolism, brain, and behavior.

Authors:  Ilia N Karatsoreos; Sarah Bhagat; Erik B Bloss; John H Morrison; Bruce S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 2.  Thyroid hormone's role in regulating brain glucose metabolism and potentially modulating hippocampal cognitive processes.

Authors:  V Jahagirdar; E C McNay
Journal:  Metab Brain Dis       Date:  2012-03-23       Impact factor: 3.584

Review 3.  Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications.

Authors:  Lawrence P Reagan
Journal:  Exp Neurol       Date:  2011-02-12       Impact factor: 5.330

4.  Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus.

Authors:  Hannah Bruehl; Oliver T Wolf; Victoria Sweat; Aziz Tirsi; Stephen Richardson; Antonio Convit
Journal:  Brain Res       Date:  2009-05-20       Impact factor: 3.252

5.  Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.

Authors:  Natalie L Rasgon; Heather A Kenna; Tonita E Wroolie; Ryan Kelley; Daniel Silverman; John Brooks; Katherine E Williams; Bevin N Powers; Joachim Hallmayer; Allan Reiss
Journal:  Neurobiol Aging       Date:  2009-12-23       Impact factor: 4.673

6.  Insulin resistance among obese middle-aged is associated with decreased cerebrovascular reactivity.

Authors:  Olivia H Frosch; Po Lai Yau; Ricardo S Osorio; Henry Rusinek; Pippa Storey; Antonio Convit
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

7.  Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.

Authors:  L Arab; R Sadeghi; D G Walker; L-F Lue; M N Sabbagh
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

Review 8.  Meditation as a therapeutic intervention for adults at risk for Alzheimer's disease - potential benefits and underlying mechanisms.

Authors:  Kim E Innes; Terry Kit Selfe
Journal:  Front Psychiatry       Date:  2014-04-23       Impact factor: 4.157

Review 9.  A look inside the diabetic brain: Contributors to diabetes-induced brain aging.

Authors:  Shayna A Wrighten; Gerardo G Piroli; Claudia A Grillo; Lawrence P Reagan
Journal:  Biochim Biophys Acta       Date:  2008-11-05

10.  Cerebral white matter and retinal arterial health in hypertension and type 2 diabetes mellitus.

Authors:  P L Yau; R Hempel; A Tirsi; A Convit
Journal:  Int J Hypertens       Date:  2013-07-29       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.